NBER WORKING PAPER SERIES

ACCOUNTING FOR GLOBAL COVID-19 DIFFUSION PATTERNS, JANUARY-APRIL
2020
Yothin Jinjarak
Rashad Ahmed
Sameer Nair-Desai
Weining Xin
Joshua Aizenman
Working Paper 27185
http://www.nber.org/papers/w27185

NATIONAL BUREAU OF ECONOMIC RESEARCH
1050 Massachusetts Avenue
Cambridge, MA 02138
May 2020

We gratefully acknowledge the insightful comments by two anonymous referees, and the
financial support by the Dockson Chair and the Center of International Studies at USC. Data and
codes available at Github Repository: https://github.com/snairdesai/COVID-19. The views
expressed herein are those of the author and do not necessarily reflect the views of the
National Bureau of Economic Research.
NBER working papers are circulated for discussion and comment purposes. They have not been peerreviewed or been subject to the review by the NBER Board of Directors that accompanies official
NBER publications.
Â© 2020 by Yothin Jinjarak, Rashad Ahmed, Sameer Nair-Desai, Weining Xin, and Joshua Aizenman.
All rights reserved. Short sections of text, not to exceed two paragraphs, may be quoted without explicit
permission provided that full credit, including Â© notice, is given to the source.

Accounting for Global COVID-19 Diffusion Patterns, January-April 2020
Yothin Jinjarak, Rashad Ahmed, Sameer Nair-Desai, Weining Xin, and Joshua Aizenman
NBER Working Paper No. 27185
May 2020, Revised July 2020
JEL No. F55
ABSTRACT
Key factors in modeling a pandemic and guiding policy-making include mortality rates associated
with infections; the ability of government policies, medical systems, and society to adapt to the
changing dynamics of a pandemic; and institutional and demographic characteristics affecting
citizensâ€™ perceptions and behavioral responses to stringent policies. This paper traces the crosscountry associations between COVID-19 mortality, policy interventions aimed at limiting social
contact, and their interactions with institutional and demographic characteristics. We document
that, with a lag, more stringent pandemic policies were associated with lower mortality growth
rates. The association between stricter pandemic policies and lower future mortality growth is
more pronounced in countries with a greater proportion of the elderly population and urban
population, greater democratic freedoms, and larger international travel flows. Countries with
greater policy stringency in place prior to the first death realized lower peak mortality rates and
exhibited lower durations to the first mortality peak. In contrast, countries with higher initial
mobility saw higher peak mortality rates in the first phase of the pandemic, and countries with a
larger elderly population, a greater share of employees in vulnerable occupations, and a higher
level of democracy took longer to reach their peak mortalities. Our results suggest that policy
interventions are effective at slowing the geometric pattern of mortality growth, reducing the
peak mortality, and shortening the duration to the first peak. We also shed light on the importance
of institutional and demographic characteristics in guiding policy-making for future waves of the
pandemic.

Yothin Jinjarak
School of Economics and Finance
Victoria University of Wellington
PO Box 600
23 Lambton Quay, Wellington
New Zealand
yothin.jinjarak@vuw.ac.nz
Rashad Ahmed
University of Southern California
3620 South Vermont Ave.
Los Angeles, CA 90089
rashadah@usc.edu
Sameer Nair-Desai
University of Southern California
3620 S Vermont Ave
Los Angeles, CA 90089
nairdesa@usc.edu

Weining Xin
Department of Economics
University of Southern California
3620 S Vermont Ave.
Kaprielian Hall (KAP), 300
Los Angeles, CA 90089
United States
weiningx@usc.edu
Joshua Aizenman
Economics and SIR
University of Southern California
University Park
Los Angeles, CA 90089-0043
and NBER
aizenman@usc.edu

I.

Introduction and Overview
This paper takes stock of the data gathered during the first three months of the COVID-19

pandemic, tracing the associations between COVID-19 mortality and pandemic policy interventions,
accounting for global pandemic diffusion patterns. Pandemic policy interventions in our consideration
refer to containment and closure policies that aim to limit social contact. Anecdotal evidence and policy
dynamics suggest that accelerated COVID-19 mortality induces a tighter pandemic policy response aimed
at slowing the otherwise geometric patterns of the pandemic. With a lag of several weeks, these policies
ought to reduce the mortality rate, with reductions varying systematically across countries. Specifically,
as COVID-19 mortality affects disproportionally the older population and people with pre-existing
conditions, a given increase in policy intensity may have a greater proportionate impact on future mortality
in older societies, and in countries with higher average exposure to pre-existing medical conditions. In
the same vein, higher urbanization rates, higher population density, and mobility, other things being equal,
ought to magnify the decline in future mortality rates associated with a more aggressive pandemic policy
stance.
Key factors in modeling a pandemic and in guiding policy-making include the infection rates; the
mortality rates associated with infections; the ability and effectiveness of the policies, medical system,
and society to adapt to the changing dynamics of a pandemic; and other structural factors [Verity, Okell,
Dorigatti et al. (2020)]. In the absence of vaccines, policies which limit social contact are a key strategy
adopted by most countries amid the COVID-19 pandemic to flatten the curve. However, the strictness and
timing of such policy interventions vary substantially across countries. Additionally, institutional and
demographic characteristics such as the proportion of elderly and urban populations, the nationâ€™s level of
democracy, etc., may influence mortality dynamics both directly through the size of vulnerable
populations, and indirectly through citizensâ€™ perceptions and behavioral responses to stringent policies
(Van Bavel et al., 2020). Our empirical specification controls for these considerations, subject to the
limited data available on key factors. Specifically, the scarcity of COVID-19 testing, and the limited
information on the precision of available tests, implies a vast underestimation of the infection rates per
capita, possibly by a factor of two digits.1 The undercount of COVID-19 population mortality rates is also
1

AAAS Science of April 21, 2020 reports a vast undercount of COVID-19 infection rates. A Stanford study by
Bhattacharya and Bendavid estimated that for each positive COVID-19 test result in Santa Clara County, California,
there are more than 50 times more infected people. Similar results were found in Los Angeles county, and in several
studies in Europe. While the debate about the methodologies and the veracity of these studies is ongoing, these

2

prevalent, but by an order of magnitude below the errors associated with infection rates.2 Therefore, we
focus mostly on accounting for the COVID-19 population mortality rates per capita during the first phase
of the pandemic, controlling for policy and structural factors subject to data availability and quality. We
plan to revisit these issues with better quality and longer-term data in the coming quarters.
A fair share of the countries reached a local peak of the COVID-19 population daily new mortality
rate curve during the sample period [see Figures 1 and 2]3. Applying various techniques, we study the
factors accounting for the empirical shape of the mortality curve from the onset of the pandemic to the
local peak, with a focus on the impact of policy intensity interacting with structural variables. Like similar
studies, one should use healthy skepticism in reading the results. First, data quality and availability are a
major limitation, as each country has its challenges with data collection, aggregation, and reporting.
Second, â€˜better performanceâ€™ in the first mitigation phase of a pandemic does not guarantee superior future
performance, as the dynamics of a new viral pandemic are yet unknown. By design, flattening the
pandemic curve shifts some mortality incidence forward. The susceptibility to secondary waves of
infection remains a looming threat.4 Policies adopted in the second quarter of 2020, and the realized
pandemic infections, containment, and treatment will explain the future performance of each country.
Furthermore, only time and much more medical research will tell the degree to which infected persons
that recovered gained immunity for a long enough period to allow smooth convergence to â€˜herd immunity.â€™
Our study relies on daily COVID-19 policy and case data reported by Oxford and John Hopkins
University, as well as Apple mobility data and various controls. Our baseline estimation study examines
results probably reflect the strong testing selectivity -- testing targeted mostly sick patients, at more advanced stages
of possible infection than is medically optimal, thereby missing large population shares of patients with mild or
asymptomatic COVID-19 symptoms.
2

A Financial Times study, April 26, 2020, reported that mortality statistics show 122,000 deaths in excess of normal
levels across 14 countries, concluding that the global coronavirus death toll could be 60% higher than reported.
This undercount reflects on the scarcity of COVID-19 tests, underreported deaths at senior homes and assisted
living centers, misdiagnoses, varying reporting lags, limited administrative capacities and the like. Ideally, we
would have preferred to identify the exact number of patients who died â€˜because of' COVID-19, but that number
remains unknown. Overtime, countries have updated the mortality data with new information, and one cannot rule
out that for some countries there may be over counting.
3
Using a conservative threshold of countries which reached the peak mortality one week prior to the end of the
sample period, roughly 39 countries out of 59 in the sample reached their first peak by the end of the first wave.
Additional visualizations on the dates of peak mortalities in the sample and which countries did not reach the peak
can be found in the GitHub.
4
A â€œbetter performanceâ€ in the first mitigation phase of a pandemic may induce a too fast opening of the economy
towards â€œbusiness as usual," reducing the public vigilance of keeping social distancing and masking. Hence, we
chose to avoid making any arguments related to the overall performance in terms of total death toll.

3

OECD and Emerging Market (EM) sub-samples based on data from 1/23/2020 â€“ 4/28/2020; or the first
97 days of the pandemic. Below, we summarize the main results.
First, we investigate the evolution of weekly mortality growth rates over time and across countries.
Applying dynamic panel analysis, local projections (Jorda, 2005) suggest that administering more
stringent pandemic policies were associated with significantly lower mortality growth rates, with a lag of
2 to 4 weeks, during the first pandemic phase (i.e., during the time from the first death through the end of
the sample period). Countries with a Stringency Index (SI) 10 units higher than average had, two weeks
later, mortality growth rates that were on average 22 percentage points lower (Oxfordâ€™s SI is normalized
between 0 to 100; where 100 = strictest response). The reductions in mortality growth rate are smaller
after three and four weeks, roughly 17 and 13 percentage points respectively. While the reduction in
growth rates seem quite large, it is important to put these numbers in perspective. Given the geometric
nature of disease spread, oftentimes, week-over-week mortality growth rates can be anywhere from +50%
to +100% or greater.
Taking slow-moving country fundamentals from the period pre-COVID-19 as exogeneous, we
find that countries in the 75th percentile in terms of proportion elderly (65 or older) saw a much stronger
reduction in mortality growth rates from the same 10 unit rise in SI, compared to countries with relatively
low proportions of elderly (25th percentile). Countries in the 75th (25th) percentile saw mortality growth
rates of about -25% (-10%) after two weeks. Countries with a greater proportion of the elderly are
unconditionally more susceptible to the pandemic, but for this same reason, they are likely to benefit more
under stringent policies. In countries with a higher proportion of urban population, SI measures had a
stronger impact on mortality growth than in countries with a lower proportion of urban population. This
heterogeneity is consistent with the fact that urban populations may face greater exposure due to their high
population densities. Greater policy stringency is also more strongly associated with lower mortality
growth during the first phase of the pandemic in countries with greater inbound travel, greater GNI per
capita, higher health expenditures and a greater level of democracy (measured with the EIU Democracy
Index).5 While international travel flows are quite intuitive risk factors for a pandemic like COVID-19,
the role of democratic freedom is an ongoing topic of debate (Ang, 2020). Our results are consistent with
the view that greater individual rights may be detrimental in this situation, making it more difficult for the
government to administer strict quarantines and have citizens abide by them.

5

The EIU Democracy Index is based on five categories: electoral process and pluralism; civil liberties; the
functioning of government; political participation; and political culture.

4

Next, we turn to cross-country regression results, where the dependent variables include the logged
peak new mortality rate (calculated as the new deaths out of the population at the peak of daily new
mortality, by country), and the ratio of â€˜peak new mortality rateâ€™-to-â€˜pandemic duration to first peakâ€™
measured in days (a proxy for flatness/steepness of the mortality rate curve). Definitions of these peakrelated dependent variables are illustrated in Figure 3 using the daily new mortality curve of Czechia.
Countries with more aggressive policy interventions in place prior to the first death tend to exhibit a lower
new mortality rate at the peak (â€œEarly SIâ€ or â€œproactive stringency policyâ€)6. We find that a one unit
increase in Early SI (average SI level prior to the first COVID mortality) is associated with peak new
mortality rates on average -12% lower. Quantitatively, early SI was also associated with flatter mortality
curves, but the estimate is statistically insignificant. Unsurprisingly, higher early mortality growth rates
(growth rate of new mortality rate in the first week following the first death) are significantly associated
with higher peak mortalities and steeper mortality curves, while higher levels of the mortality rate early
on (cumulative mortality rate within the first week following the first death) were associated with flatter
overall mortality curves.7 Greater early mobility was also significantly associated with higher mortality
peaks. Higher population density is, somewhat surprisingly, associated with flatter mortality curves
(column [2]). However, this association may be driven by the fact that many of the high-density countries
are in Asia. Overall, the evidence suggests (but does not necessarily assert) that policy stringency directly
reduced the peak mortality rates, and that other forces were also at play (e.g., early mobility, initial
pandemic conditions, institutional features).
Not only do mortality rates during the first pandemic phase differ across countries, there is also
considerable variation in how long new deaths continued to climb in terms of days. We term this as the
â€˜pandemic duration to the first peakâ€™ (PD). One should be careful when interpreting the effects of
covariates on the PD in terms of altering the shapes of mortality curves, as a longer PD could be
accompanied by a higher peak mortality rate and thus a steeper curve, or a lower peak mortality rate and
thus a flatter curve. Fitting a Kaplan-Meyer curve for the PD over all countries in the sample, in number
of days, suggests that countries with stronger Early SI measures (above the average) had significantly
lower PDs on the way to the first local peak of the mortality/day curve, compared to countries which did

6

Higher Early SI measures in some countries, for example, often reflect the use of international travel bans or
â€˜shelter-in-placeâ€™ policies that were announced in anticipation of a pandemic breakout.
7
Including early mortality growth in the cross-country regression also knocks out the significant effect on elderly
population. Itâ€™s possible that countries with higher early mortality growth rates are also countries with higher
proportion elderly. These countries would realize more deaths early on given the at-risk population is larger.

5

not. The probability of peaking after 40 days is close to 0% for above-average Early SI countries (virtually
all of these countries experienced their first local peak by day 40). For below-average Early SI countries,
it took approximately 80 days, twice the amount of time, until the first peak was reached. To better
understand the cross-country variation in PD, we estimate a Cox proportional hazards model. Higher
mortality rates early on are associated with shorter pandemic durations to the peak, while countries
realizing higher mortality peaks tend to have, unsurprisingly, longer pandemic durations to the peak.
Although the negative association between the strictness of early policy interventions and the pandemic
duration to the peak is not significant under the Cox model, more aggressive policy interventions early on
could still be associated with a shorter pandemic duration to the peak through reducing mortality peaks as
evidenced by the cross-country analysis. Countries that responded faster prior to the first death had shorter
pandemic duration to the peak. Additionally, countries with greater proportions of elderly populations,
greater proportions of urban population, greater shares of vulnerable employment tend to exhibit shorter
pandemic durations to the peak.8 Moreover, under certain specifications, the level of democratic freedom
appears to be a highly significant determinant in pandemic duration to the peak. That is, countries that
have a higher level of democracy saw longer pandemic durations to the peak. Countries further away from
the equator also tended to experience longer PD. While at this stage we are reporting suggestive statistical
associations, more data and research are needed to get fuller identifications of all these factors.

II.

Empirical Specification
We focus on two aspects of COVID-19 mortality over the first three months of the pandemic

spanning from January 23rd, 2020 to April 28th, 2020, which we refer to as the first pandemic phase: first,
the dynamic of COVID-19 mortality rates out of the total population, examining the weekly growth rate
of the new mortality rate per capita; and second, the empirical shape of the mortality rate curve from the
onset to the local peak of the first pandemic phase, examining three dependent variables discussed below.
To filter out noise in the daily mortality data, we construct a 7-day rolling average of the daily mortality
rate per capita and use these series of averages in our estimations and peak identifications. For simplicity,
the mortality rate mentioned hereafter is referred to as the 7-day rolling average of the mortality rate.
Although examining the growth rate of the new mortality rate per capita provides evidence on how
mortality rates evolve over time, it is not trivial to conclude which variables can characterize the cross8

This result, which seems counterintuitive, is consistent with our findings in the dynamic panel analysis, where
countries exhibiting these same risk factors also had more effective stringency policies in terms of reducing
mortality growth rates.

6

country difference in the empirical shape of the mortality curve from the onset to the local peak of the first
pandemic phase. We argue that three outcome variables related to the local peak matter: first, the new
mortality rate at the peak; second, the pandemic duration to the peak; third, the ratio of the new mortality
rate at the peak to the pandemic duration to the peak. We illustrate this idea by comparing country cases.
Figure 4 shows the daily new mortality rate curves for several countries: the left one comparing that of
Hungary and Norway, the middle one comparing to that of Denmark and Norway, and the last one
comparing that of Austria, Estonia, and Greece. The left figure shows that although the peak mortality
rates of Hungary and Norway are around the same, their durations to the peak are different: Norway
reached the peak faster, and thus had a steeper mortality curve. The middle figure shows that although the
durations to the peak of Denmark and Norway are around the same (i.e., both around 25 days), their peak
mortality rates are different: Denmarkâ€™s mortality rate climbed to a higher level before going down, and
thus had a steeper mortality curve. Hence, a lower peak mortality rate or a longer duration to the peak
implies a flatter mortality curve; however, only on the condition that all other things are held equal. Once
both the peak mortality rate and the duration to the peak change in the same direction, it may be ambiguous
whether the mortality curve is flattened or not, as demonstrated in the right figure of Figure 4. Both Estonia
and Greece realized a lower peak mortality rate and a shorter duration to the peak than Austria; however,
it is obvious that Estonia has a much steeper mortality curve while Greece has a much flatter mortality
curve compared with Austria. This implies that the ratio of the peak mortality rate to the duration to the
peak also plays a key role in understanding the empirical mortality curve. Hence, it follows that all three
outcome variables related to the peak (including the daily new mortality rate at the peak, the duration to
the peak, and the ratio of the peak rate to the duration) together characterize the empirical shape of the
mortality curve from the onset to the local peak of the first pandemic phase. By knowing how these three
outcome variables are impacted by government pandemic policies or country-specific structural variables
can we uncover to what extent these factors account for the pattern of mortalityâ€™s climb to the local peak
of the first pandemic phase.
II.i. Policy stringency and mortality dynamics
We start with a panel study of mortality growth rate dynamics, using the week-over-week growth
rate of the new mortality rate per capita, accounting for containment and closure policy interventions (see

7

Oxfordâ€™s COVID-19 Government Response Tracker). 9 Specifically, our dependent variable ğ‘¦ , in
country ğ‘– on date ğ‘¡ is defined as
(1)
ğ‘¦,

log ğ‘€ğ‘œğ‘Ÿğ‘¡ğ‘ğ‘™ğ‘–ğ‘¡ğ‘¦ğ‘…ğ‘ğ‘¡ğ‘’ ,

log ğ‘€ğ‘œğ‘Ÿğ‘¡ğ‘ğ‘™ğ‘–ğ‘¡ğ‘¦ğ‘…ğ‘ğ‘¡ğ‘’ ,

,

where ğ‘€ğ‘œğ‘Ÿğ‘¡ğ‘ğ‘™ğ‘–ğ‘¡ğ‘¦ğ‘…ğ‘ğ‘¡ğ‘’ , is the new mortality rate in country ğ‘– on date ğ‘¡. A lower growth rate of the new
mortality rate implies a flattening of the mortality curve.
Our first benchmark estimation uses the method of local projections (Jorda, 2005), examining
future (or current) mortality growth rate as a function of current (or past) mortality growth rate and degree
of policy stringency. We aim to understand to what degree policy interventions are associated with future
mortality growth, and therefore, the evolution of the pandemic. Local projections do not only simplify our
problem but also produce robust estimates under misspecification10. Specifically, our model is
(2)
ğ‘¦,
where ğ‘¦ ,

ğ›¼ â„

ğ›¿ â„

ğ›¾ â„ ğ‘†ğ¼ ,

ğ›½ â„ ğ‘¦,

ğœ€, â„ ,

is the week-on-week growth rate of the new mortality rate in country ğ‘– at date ğ‘¡

â„ for â„

14, 21, 28 . ğ‘†ğ¼ , is the Stringency Index constructed in the Oxford COVID-19 Government Response
Tracker, an aggregate measure of the overall stringency of containment and closure policies,11 at date ğ‘¡
and ğ‘¦ ,

is the one-day lagged mortality growth rate. Fixed effects are denoted as ğ‘ and ğ›¿ , representing

the country and time fixed effects, respectively. We choose to examine the response of new mortality
growth with respect to SI at horizons no shorter than two weeks, with reference to studies on the incubation
and death periods: The incubation period is 6 days on average (McAloon, et al., 2020), and the death
period (number of days from symptom onset to death) ranges from 12 to 15 days for different age groups
9

Oxfordâ€™s Government Response Tracker
Local projection methods have become widely popular for macroeconomic analysis (see Ramey and Zubairy
(2018) for a recent application), specifically for estimating impulse response functions. They are shown to be robust
to misspecification and very easily allow for non-linearities (which we introduce when studying heterogeneity).
The basic idea is that a series of regressions are estimated, where in each regression the dependent variable is shifted
one period forward for â„ periods. This results in a series of â„ regressions outputs (referred to as the set of local
projections) with â„ regression coefficient sets, which are used to trace out the dynamic response of the dependent
variable from a shock to a particular covariate.
11
Stringency Index (SI) is calculated by taking the ordinal value and adding a weighted constant if the policy is
general rather than targeted, if applicable, which are then rescaled by their maximum value to create a score between
0 and 100, with a missing value contributing 0. Hence it captures the average intensity of containment and closure
policies. More information can be found at Oxfordâ€™s Government Response Tracker.
10

8

on average according to CDC estimates.12 The collection of estimates ğ›¾ â„ for â„

14, 21, 28 trace out

the dynamic impact of stringency policies on mortality growth at the weekly frequency13.
Additionally, we study the heterogeneity in the association between policy interventions and
mortality growth by estimating the model with interaction terms between the Stringency Index and
country-specific social and economic variables
(3)
ğ‘¦,

ğ›¼ â„

ğ›¿ â„

ğ›¾ â„ ğ‘†ğ¼ ,

ğ›½ â„ ğ‘¦,

ğœƒ â„ ğ‘†ğ¼ , âˆ— ğ‘¥

ğœ€, â„ ,

where ğ‘¥ is the country-specific variable of interest. We consider: the proportion of the elderly population
(people aged 65 and over), the proportion of the urban population, proportion of employment in vulnerable
sectors, population density, the logarithm of GNI per capita, health expenditure (% of GDP), populationweighted exposure to ambient PM2.5 pollution, the logarithm of tourist arrivals and departures, level of
democracy, and country location measured with latitude and longitude.14
II.ii Cross-country differences in peak mortality
We follow with a cross-country analysis examining the mortality rate at the peak, a key moment
in the first quasi-bell curve, which puts hospitalsâ€™ capacity to their most severe test. The quasi-bell shapes
are normalized by the day of the first significant death. As discussed before, we consider three outcome
variables related to the peak: first, the logged peak mortality rate, second, the pandemic duration to the
first peak (PD), and third, the ratio of the logged peak mortality rate to the PD. We opt to use linear
regression analysis to examine the cross-country difference in the logged peak mortality rate and the ratio
of the logged peak mortality rate to the PD and use survival analysis to examine the cross-country
difference in the PD. Our cross-country peak mortality data is calculated from the sample from January
23rd, 2020 to April 28th, 2020, during which many OECD countries and emerging market economies
finished their ride up to the first peak of the first quasi-bell in terms of contagion per capita and fatality
per capita.
Our cross-sectional linear regression model is

12

See https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html#table-2.
Reporting week-on-week estimates instead of daily ensures that the results are estimated on non-overlapping
periods.
14
The range of the latitude is from -90 to 90 and the range of the longitude is from -180 to 180, indicating that
each country is uniquely identified by an interaction of the latitude and longitude.
13

9

(4)
ğ‘¦

ğ›½

ğ‘ğ›¾

ğ‘‹ğ›½

ğœ€,

where ğ‘¦ is the logged peak mortality rate or the ratio of the logged peak mortality rate to the PD
in country ğ‘–. A higher peak mortality rate implies a larger inflow of patients, stretching hospitalsâ€™ capacity.
Accounting for the pandemic duration to the first peak, a higher ratio of the logged peak mortality rate to
the PD implies a steeper mortality curve, characterized by either a larger or a faster patient inflow that
could potentially overwhelm the healthcare system. We include a set of potential endogenous variables
ğ‘ . First, one may be interested in whether the cross-country difference in the intensity of the COVID-19
outbreak explains the cross-country difference in the empirical shape of the mortality curve. We include
log ğ¸ğ‘ğ‘Ÿğ‘™ğ‘¦ ğ‘€ğ‘œğ‘Ÿğ‘¡ğ‘ğ‘™ğ‘–ğ‘¡ğ‘¦ , the logged cumulative mortality rate in the first week after the first death, and
ğ¸ğ‘ğ‘Ÿğ‘™ğ‘¦ ğ‘€ğ‘œğ‘Ÿğ‘¡ğ‘ğ‘™ğ‘–ğ‘¡ğ‘¦ ğºğ‘Ÿğ‘œğ‘¤ğ‘¡â„ , the growth rate of daily mortality rate in the first week after the first death,
to control for the cross-country difference in the initial level and growth of the mortality rate. Second, one
may be interested in whether proactive stringency (i.e., stringency policies in place before the first reported
death) policy interventions influence the cross-country difference in the empirical shape of the mortality
curve. We also include ğ¸ğ‘ğ‘Ÿğ‘™ğ‘¦ ğ‘†ğ¼ , the average of the Stringency Index (SI) from its first non-zero value
to the first death, accounting for how strict government interventions were before the first confirmed death,
and ğ·ğ‘ğ‘¦ğ‘  ğ‘“ğ‘Ÿğ‘œğ‘š ğ¹ğ‘–ğ‘Ÿğ‘ ğ‘¡ ğ‘†ğ¼ ğ‘¡ğ‘œ ğ¹ğ‘–ğ‘Ÿğ‘ ğ‘¡ ğ·ğ‘’ğ‘ğ‘¡â„ , the number of days from the first non-zero SI to the first death,
accounting for how early government interventions are implemented. Additionally, to account for crosscountry differences in how aggressively countries respond to the pandemic and increase their policy
intensities, we include a variable which we refer to as the ğ‘†ğ¼ ğ·ğ‘’ğ‘™ğ‘¡ğ‘ (or Stringency Delta), calculated as
the difference between a countryâ€™s maximum level of SI and its initial level of SI (ğ‘†ğ¼ , ), normalized by
the number of days (ğ‘‡ ) between them:
(5)
ğ‘†ğ¼ ğ·ğ‘’ğ‘™ğ‘¡ğ‘

max ğ‘†ğ¼
ğ‘‡

ğ‘†ğ¼ ,

.

A higher maximum SI and/or a shorter time to the maximum SI will yield a higher SI Delta. Third, we
include ğ¸ğ‘ğ‘Ÿğ‘™ğ‘¦ ğ‘€ğ‘œğ‘ğ‘–ğ‘™ğ‘–ğ‘¡ğ‘¦ , the weekly average mobility index in terms of walking (reported by Apple) in
the week before the first death. We emphasize that while these variables are important to investigate, all
of them are endogenous, as they are calculated over part of the first wave period of COVID-19. We also
include a set of country-specific control variables ğ‘‹ that we take as exogenous, including the proportion
10

of the elderly population (people aged 65 and over), the proportion of the urban population, proportion of
employment in vulnerable sectors, population density, GNI per capita, health expenditure (% of GDP),
level of democracy, and country location measured with latitude and longitude.
II.iii. Cross-country differences in time-to-peak
We then proceed with a survival analysis studying the association between the pandemic duration to
the first peak (PD) and a set of explanatory variables. We focus on the survival function of the mortality
peaking
(6)
ğ‘† ğ‘¡ = Pr(T > t),
which is defined as the probability that the PD is later than date ğ‘¡, which is the probability that the mortality
peaks after date ğ‘¡. A higher probability that the PD is later than a certain date implies a longer PD, which
could have ambiguous implications. On the one hand, it suggests a slower surge in hospitalization that
could ease the burden on the healthcare system. On the other hand, a longer time-to-peak may imply a
longer-lived, poorly managed pandemic.15 Our benchmark specification is the Cox proportional hazards
model (Cox, 1972), which examines the relationship between the hazard function and a set of explanatory
variables.16 The hazard function is defined as the probability that the peak is on date ğ‘¡ conditional on that
the peak is reached until date ğ‘¡ or later,
(7)
ğœ† ğ‘¡

lim
â†’

Pr ğ‘¡

ğ‘‡ ğ‘¡
ğ‘‘ğ‘¡ âˆ™ ğ‘† ğ‘¡

ğ‘‘ğ‘¡

ğ‘† ğ‘¡
.
ğ‘† ğ‘¡

Our benchmark Cox proportional hazards model is
(8)
ğœ† ğ‘¡|ğ‘ , ğ‘‹

ğœ† ğ‘¡ exp ğ›½

15

ğ‘ğ›¾

ğ‘‹ğ›½ ,

Without accounting for the peak mortality rate or the cumulative mortality rate, a longer pandemic duration to
the first peak could be accompanied by a higher daily new mortality rate at the peak.
16
The assumption of the Cox Model is that the variable of interest has a time-invariant multiplicative effect on the
hazard of COVID-19 deaths (see George et al. (2014) for a review of survival methods), which will be verified in
section IV.

11

where ğœ† ğ‘¡|ğ‘‹ is the hazard function for country ğ‘– on date ğ‘¡, conditioning on a set of endogenous variables
ğ‘ and exogenous variables ğ‘‹ , and ğœ† ğ‘¡ is the baseline hazard function. In addition to the same set of
endogenous and exogenous variables as in the cross-country regression analysis, we also include the
endogenous logged peak new mortality rate, log ğ‘ƒğ‘’ğ‘ğ‘˜ ğ‘€ğ‘œğ‘Ÿğ‘¡ğ‘ğ‘™ğ‘–ğ‘¡ğ‘¦ , to control for the cross-country
difference in the peak level of mortality rates. The specification of the Cox Model implies that the effect
on the hazard function of a one-unit increase in one covariate ğ‘¤ âˆˆ ğ‘, ğ‘‹ with coefficient ğ›¿ is to multiply
the hazard function by ğ‘’ , and that the effect on the survival function is to raise it to a power given by the
effect on the hazard function
(9)
ğ‘† ğ‘¡

ğ‘† ğ‘¡

,

where ğ‘† ğ‘¡ is the survival function on date ğ‘¡ for a group with a one-unit higher value of the covariate ğ‘¤,
all other variables held constant.
II.iiii. Limitations
We wish to briefly call out the limitations of our research design. First, our estimates cannot (and should
not) be interpreted as causal. What we are reporting, across all models, are associations. Some of our
variables are endogenous, which may bias our estimates. Moreover, given our choice to investigate
country factors one-by-one, our regression estimates may also be biased from omitted variables. To
overcome these challenges, we are in the process of collecting additional data at varying levels of detail
to help deal with these issues, with the aim of achieving cleaner identification going forward. Nonetheless,
under such data constraints, we believe our approach strikes a balance between parsimony, robustness,
and informativeness.
III.

Data
Our data relate prudential and reactionary government interventions to COVID-19 mortality rates

per capita, controlling for country-specific characteristics. We construct the mortality rates using the John
Hopkins Center for Systems Science and Engineering (CSSE) COVID-19 data repository, which details
confirmed cases and deaths across our sample period. The seven-day rolling average of the new mortality
rate per capita is calculated as the ratio of the cumulative total of country deaths by population, while the
seven-day rolling average of the cumulative mortality rate is the ratio of new daily deaths by population.17
17

Population data was pulled from the United Nations. Note this calculation differs from the fatality rate per
capita; which is calculated by epidemiologists as the ratio of deaths to cases per capita.

12

This data, which is provided as a global panel at the provincial level, was aggregated to the country-level
for the purposes of our estimation. Our full sample considers 59 Advanced Economy (AE) and Emerging
Market (EM) countries18. We choose to exclude developing nations from this first sample for two reasons.
First, data quality and availability in these nations is poor over our sample period. Additionally, many of
these developing nations experienced lags in the contagion of the virus, thus hitting their peaks later than
global hubs like Europe and the United States.19
The central covariates of interest were pulled from Oxfordâ€™s COVID-19 Government Response
Tracker. As of April 29th, 2020, Oxford provides country-level indicators on containment and closure,
economic responses; the quality of health systems; and unorthodox responses to the COVID-19
pandemic.20 Of the 59 countries in our sample, government response data is reported for 55. We focus our
estimation on the Stringency Index (SI), which mainly captures variation in government policies related
to containment and closure. Each nation is scaled with a composite score from 0-100, with higher scores
indicating more stringent policy interventions. In our dynamic panel estimation, we lag these interventions
by between 2-5 weeks to account for delayed implementation or latent effects.
In addition to the Oxford data, we control for various country-specific features using a wide range
of publicly available data. We pull country coordinates from Google and integrate data on recent mobility
trends from Apple.21 From the World Bank, we gather World Development Indicators for the proportion
of the population above age 65; the proportion of the population which is urban; total population density
(people per 100 sq. km. of land area); tourist arrivals and departures; the proportion of vulnerable
employment; gross national income per capita (calculated in current USD using the Atlas method); the
number of cellular subscriptions; current health expenditures; and micrograms of PM2.5 air pollution per
capita.22 We also include cross-country indicators of the strength of democracy, from the Economist and

18

The analysis relies on Advanced and Emerging Market countries due to relatively more reliable and readily
available of these countries compared to lesser developed countries. AE classifications are taken from The
International Monetary Fund (IMF) while EM classifications are taken from the IMF and MSCI.
19
With the notable exception of Iran (63 days), developing countries excluded from the sample had all recorded
their first one hundred cases less than 50 days since the end of the sample on April 28th. Only eleven out of sample
developing nations had recorded more than one hundred deaths by the end of the sample period. Future research
will integrate developing nations into a larger global sample, as data availability and quality become more robust
in later phases of the pandemic.
20
A detailed review of Oxfordâ€™s dataset may be found here.
21
The data from Google can be found here; while the data from Apple was pulled from here. The Apple data is
calculated at a base of 100, where reduced daily mobility results in a lower score (<100), while higher mobility
results in a higher score (>100). Mobility is measured across walking, driving, and public transit.
22
All of these data sources can be found through the World Development Indicators.

13

Freedom House.23 From the Correlates of War Project, we aggregate data on military expenditures and
personnel, iron and steel production, and energy consumption.24 Lastly, we collect data on prior infections
and deaths by the disease through the World Health Organizationâ€™s International Classifications of
Diseases.25 This data is collapsed by country, across the years 2015-2018. The analysis is restricted to
deaths by respiratory, endocrine, or high blood pressure conditions. We choose not to incorporate testing
covariates, given discrepancies, and measurement error in currently available data.26 Depending on the
quality of future data, we may choose to integrate these covariates in our future analyses.
IV.

Estimation and Results
We take a multi-faceted approach to understand the cross-country dynamics of pandemic diffusion.

As mentioned, the dynamic panel enables us to study to what degree stringency policies are associated
with weekly mortality growth rates, and whether such policies start taking effect with a lag. We include
the Stringency Index at date ğ‘¡ and one-day lagged mortality growth (date ğ‘¡

1), and then estimate a set

of specifications with the independent variable being weekly mortality growth two to four weeks from
date ğ‘¡ via LSDV27. Given that residuals within countries are likely correlated, we employ robust standard
errors clustered by country.
Then, moving to cross-country analysis we focus on explaining differences in mortality outcomes
at the peak of the first quasi-bell curve. For this, we rely on OLS estimation, adjusting the standard errors
for heteroscedasticity. Finally, we conduct a cross-country survival analysis to better understand what
drives variation in pandemic duration to the first peak (PD) across countries. Initially, we employ a crosscountry Kaplan-Meyer analysis on the number of days to the first new mortality peak, subsequently
extending it under a Cox proportional hazard model to introduce additional controls, estimated via
maximum (partial) likelihood. For robustness, we also test and report whether the proportional hazards
assumption is satisfied.

23

Data from the Economist was pulled from the Economist Intelligence Unit; and from Freedom Houseâ€™s Freedom
in the World scores.
24
Data was pulled from the National Material Capabilities index.
25
Data from the International Classification of Diseases (V10) can be found here.
26
Testing data was originally pulled from the Our World in Data project, but is excluded in our first round of
analysis.
27
Estimates from the first specification, LSDV estimation of a model where mortality growth is lagged by 1 week
with time/country fixed effects are potentially biased (Nickell, 1981) under small ğ‘‡. However, given the large time
dimension of our panel, the LSDV estimator performs comparatively well to bias-corrected approaches (Judson and
Owen, 1999).

14

IV.i. Stringency Policy and Mortality Dynamics
Table 1 reports the baseline results from the local projection regressions (dynamic panel analysis).
Notice that across local projection regressions at horizons two to four weeks, Stringency is statistically
significant and negative. 28 These cursory results suggest that countries administering more stringent
pandemic policies realized, on average, significantly lower mortality growth rates, with a lag of two to
four weeks (Figure 5). The estimated effect sizes are also economically significant: countries with a
Stringency Index (SI) 10 units higher than average in week W realized mortality growth rates that were
on average 22, 17, and 13 percentage points lower in weeks W+2, W+3 and W+4, respectively. While the
reductions in growth rates seem quite large (and certainly should not be ignored), it is important to put
these numbers in perspective. Given the exponential nature of disease spread, weekly mortality growth
rates are highly volatile, potentially reaching anywhere from +50% to +100% (or greater).
In the baseline analysis (Table 1) we do not explore cross-country heterogeneity in mortality
dynamics. However, it is of great interest to understand whether and to what degree stringency policies
were more effective in some countries than others in slowing down mortality growth. In the Appendix,
we report local projection regression results which allow for the impact of SI to depend on each of our
country fundamentals following Equation 3. We take these country fundamentals as exogenous, as they
are from the period pre-COVID-19 and are highly persistent (e.g., population, democracy). Due to the
number of country fundamentals we are interested in exploring, we estimate regressions one-by-one.
While this yields parsimonious interpretations and preserves degrees of freedom, a key drawback of this
approach is that it may suffer from omitted variables. That the estimates of policy stringency became
statistically insignificant when its interaction with some of the country fundamentals may suggest that the
level of stringency applied was correlated with several pre-conditioning variables in the first-wave of
COVID-19.
Figure 6 characterizes the results into impulse response plots, highlighting the impact of a 10 unit
rise in SI for countries in the 25th percentile of a given characteristic against those in the 75th percentile of
the same characteristic. For example, notice that countries in the 75th percentile in terms of proportion
elderly (65 or older) saw a much stronger reduction in mortality growth rates from the same 10 unit rise
in SI, compared to countries with relatively low proportions of elderly (25th percentile): Countries in the
28

The significance disappears at horizons more than 30 days, so we only report results at horizons two to four weeks.

15

75th (25th) percentile saw mortality growth rates fall about -25% (-10%) two weeks later. These results are
consistent with the proportion of the elderly being a risk factor for the pandemic. Countries may be more
susceptible to the pandemic conditional on a greater proportion of the elderly, and for this same reason,
stringency policies may be more beneficial in these countries.
We also find that in countries with a higher proportion of urban population, SI measures had a
stronger impact on mortality growth than in countries with a lower proportion of urban population. This
heterogeneity is be consistent with the proportion of urban population being a risk factor for the pandemic
as urban population may face greater exposure possibility. SI policies are also more strongly associated
with lower mortality growth in countries with greater international travel arrivals, greater GNI per capita,
higher health expenditures, and greater EIU Democracy. While greater international flow is quite an
intuitive risk factor for a pandemic like COVID-19, the role of democratic freedom is an ongoing topic of
debate. Our results may support the view that greater ex ante individual liberties may be detrimental in
the present situation in the sense that they increase the risk of pandemic severity (thereby leading to a
stronger effect of mandated SI policies).29 While our results suggest that stringency policies were more
impactful among countries that are considered more democratically free, the effectiveness of governments
at responding to Covid-19 also depends on other complementary factors, notably leadership and
administrative capacity (Ang, 2020). The specific channel the association captures is not clear at this point,
but itâ€™s possible that countries with higher EIU Democracy scores also exhibit greater ex-ante mobility.
Alternatively, itâ€™s possible that there is greater variance in publicly available information among high EIU
countries, inducing differential beliefs related to the seriousness of the pandemic. Both scenarios can
potentially lead to greater pandemic risk, and therefore greater stringency policy effectiveness.
IV.ii. Kaplan-Meyer Curves of Pandemic Duration-to-Peak across Countries
Figure 7 reports Kaplan-Meyer (KP) curves on PD (pandemic duration to the first peak). The Yaxis can be interpreted as the â€˜probability of peaking later than day (t)â€™ or equivalently, as the â€˜probability
the first peak is yet to come by day (t).â€™ The LHS plots the unconditional duration probability and shows
how the probability the peak is yet to come is decreasing with the number of days since the first death
increases (X-axis). About 35 days into the pandemic, the probability of peaking reaches 50%; 45 days
into the pandemic, the probability rises to 75%. The center chart plots the KP curves of countries stratified
by early SI policy (above versus below average). According to the KP curve, pandemic durations were

29

Civil liberties is one of the five categories based on which the EIU Democracy Index is calculated.

16

significantly shorter in countries which proactively issued more stringent policies. That is, for high Early
SI countries, the probability of peaking reached 25% by about 35 days while it took close to 50 days for
countries with low Early SI policies. The probability of peaking after 40 days is close to 0% for high Early
SI countries (virtually all of these countries experienced their first local peak by day 40). For low Early
SI countries, it took approximately 80 days, twice the amount of time, until the first peak was reached.
IV. iii. Cross-country differences in COVID-19 mortality
Not only is there wide variation in mortality dynamics, but we also observe significant
heterogeneity in mortality peaks and curvatures across countries. Cross-section regression results, where
the dependent variable is the logged peak new mortality rate (calculated as the deaths/population at the
first peak of daily new deaths) are reported in Table 2, column [1]. In addition, we include results for the
outcome logged peak new mortality rate to PD (column [2]), and results from the survival analysis via
Cox regression on PD itself (column [3]). Several broad patterns emerge.
First, early stringency measures are significantly negatively associated with mortality peaks:
Greater early stringency is associated with lower peak mortality rates (column [1], an estimate of -0.12),
implying that countries with Early SI 1 unit higher than average realized first mortality peaks that were
about -12% lower. Quantitatively, greater policy stringency early on was also associated with flatter
mortality curves (column [2]), but the estimate is statistically insignificant. However, there is a significant
negative association between logged peak mortality rates and the PD, which implies that more aggressive
policy interventions early on may still be associated with a shorter PD through its negative impacts on
mortality peaks. Additionally, we find no evidence suggesting that the timing of initial policy interventions
is correlated with the peak or slope of mortality curves (columns [1] and [2]). Unsurprisingly, higher early
mortality growth rates are significantly associated with higher peak mortalities and steeper mortality
curves (columns [1] and [2]), while higher levels of the mortality rate early on were associated with flatter
overall mortality curves, but longer pandemic durations to the first peak (columns [2] and [3]). Greater
early mobility was significantly associated with higher mortality peaks (columns [1]) and faster response,
that is a larger number of days between the first non-zero SI and the first death, was significantly associated
with shorter pandemic duration (column [3]). Countries with greater elderly populations, greater
population density, and/or greater shares employed in vulnerable sectors saw, on average, significantly
longer PDs (column [3]). At the same time, countries scoring higher in EIU Democracy and those further
from the equator realized shorter PDs. Higher population density is, somewhat surprisingly, associated
with flatter mortality curves (column [2]). However, this association may be driven by the fact that many
17

of the high-density countries are in Asia. These countries contained the spread of COVID-19 relatively
effectively, given their preparedness in light of battling SARS in 2003. We find no cross-sectional
evidence of increasing SI policies during the pandemic (Stringency Delta) affecting peak mortalities or
PD.
The cross-sectional regression and survival analysis results, taken together with the evidence from
local projections in our dynamic panel analysis, indicate (but do not assert) that 1) aggressive policy
responses may have helped slow down the growth rate of new mortalities with a lag, 2) having stringent
policies in place early may have helped to lower peak mortality rates and PD (through reducing peak
mortality rates). In contrast, evidence on the effectiveness of increasing the SI after the fact (via Stringency
Delta) on peak mortality is much weaker.
IV.iv. Discussion and Robustness
To summarize, we investigate the impact of stringency policies on mortality growth dynamics,
along with cross-country patterns in the empirical shape of the mortality curve. First, we find that higher
SI levels were significantly associated with lower mortality growth rates with a lag of 2, 3, and 4 weeks.
The effect of a 10-unit rise in the SI levels on future mortality growth was stronger in countries that appear
to be more vulnerable ex-ante to COVID-19 type breakouts: countries with greater elderly populations,
cooler temperatures, more international travel flow, and higher levels of the EIU Democracy index. In
terms of peak mortality rates across countries, we find that proactive stringency policies (Early SI) â€“ those
already in place prior to the first reported mortality - were significantly associated with lower mortality
peaks, while higher mobility levels were significantly associated with higher mortality peaks. As for
pandemic duration-to-first peak, higher mobility levels were associated with shorter average pandemic
durations (despite higher mortality peaks), while greater elderly population and greater shares of
employment in vulnerable sectors were associated with longer average pandemic durations. Estimates
from a Kaplan-Meyer analysis indicate that proactive stringency policies early on were associated with
significantly shorter PD.
We have conducted several robustness checks. First, to explore the potential nonlinear effect of SI
on weekly new mortality growth, we replace the level variable of SI in the local projection method by the
logarithm transformation of SI. Results are similar to our main findings: there were significantly negative
associations between weekly new mortality growth and the log ğ‘†ğ¼ at horizons two to four weeks.
Specifically, a ten percent increase in SI was associated with 7.1, 5.8, and 4.7 percentage points decrease
in weekly new mortality growth rates, at horizon two, three and four weeks, respectively. These results
18

suggest nonlinearity in the effects of SI on weekly new mortality growth rates: an increase in SI when the
SI level is low is likely to have a greater effect on reducing mortality growth rates. Such nonlinearity is
also consistent with the finding in the cross-sectional analysis that countries had a greater average SI
before the first death saw a lower new mortality rate at the peak. Second, in addition to closure and
containment measures, the SI constructed by Oxford COVID-19 Government Response Tracker considers
public information campaigns, which may be argued as different from closure and containment measures.
Hence, we check this by constructing an alternative SI excluding the public information campaigns.
Additionally, we construct a second alternative SI which only consists of domestic closure and
containment measures, 30 as many countries implemented international travel restrictions early and
aggressively while not carrying out domestic closure and containment policies. Results using these
alternative SIs are similar to our main findings: alternative measures of stringency were significantly and
negatively associated with weekly new mortality growth, at horizons two to four weeks. Third, we
experiment with including lagged SI as controls and find similar results.31
In the Appendix, we also report a robustness check using growth in cumulative mortalities (as
opposed to growth in new mortalities) and a first pass at a residual analysis based on our benchmark
estimation, identifying countries which appear to be statistical outliers.32 There are countries oft-cited in
the public discussion as exceptionally better or worse than predicted in terms of their infection and
mortality rates, several of which are consistent with the residuals in our estimation. The contributing
factors are likely to be many, including that several of these countries previously experienced recent
outbreaks, including SARS-CoV-1 (2002-2004). These include: (i) mortality rates worse than expected:
Brazil, Ecuador, Iran, Italy, Peru, United States; (ii) mortality rates better than expected: Cambodia,
Greece, India, Indonesia, Iraq, Japan, Lebanon, Myanmar, South Korea, Sub-Saharan Africa (including
Ebola-affected areas), Thailand, Venezuela, Vietnam. Japan, for example, offers an interesting case study
with its proximity to the initial hotspots (China and South Korea), but is currently cited as successfully
managing the infection and mortality rates without lockdown or mass testing (Bloomberg, 2020).
Additionally, the degree of enforcement of policy intervention rules may be of great importance in
30

Specifically, indicators with ID C1-C7 in Oxford COVID-19 Government Response Tracker.
All results of robustness checks are shown in Appendix.
32
Results of the panel analysis on cumulative mortality growth rates are broadly consistent with that on new
mortality growth: Greater policy stringency is associated with lower cumulative growth, with a lag, and the
association is more persistent (significant up to five weeks later). Also, we observe heterogeneity in the associations:
Such associations are more pronounced in countries with a greater proportion of elderly population, a greater
proportion of urban population, further away from equator, a higher level of GNI per capita, a greater share of health
expenditure, and a higher level of democracy.
31

19

explaining the cross-country difference in the empirical shape of the mortality curve, which, however,
lacks data to measure. As the pandemic continues to unfold and as new data comes in, weâ€™ll continue the
process of analyzing these exceptional cases for country-specific factors underlying their mortality rates
from COVID-19.
V.

Related Studies
Avery et al. (2020) provide an overview of the modeling of the spread of COVID-19. By and large,

the ongoing challenges surround data on the infection rates. As noted by Manski and Molinari (2020),
because of missing data on tests for infection and imperfect accuracy of tests, reported rates of population
infection by the SARS CoV-2 virus are lower than actual rates of infection, resulting in infection fatality
rates that are lower than reported. In addition, as argued by Atkeson (2020), in the presence of effective
mitigation measures, the model with a high initial number of active cases and a low fatality rate gives the
same predictions for the evolution of the number of deaths in the early stages of the pandemic as the same
model with a low initial number of active cases and a high fatality rate. Modeling the COVID-19 infection
also face with uncertainty about the evolution of infection rates, due to parameter uncertainty and the
realization of future shocks (Liu et al., 2020). To ameliorate these empirical challenges, our study uses the
mortality rate per capita as the main variable of interest. In this section, we synthesize our estimates with
findings from related studies in the field. Notwithstanding different empirical specifications across studies,
we find our main results are consistent and communicable with the literature and offer valuable new
evidence.
V. i. Mortality rates
Closely related to our study are The Economist (2020), Stojkoski et al. (2020) and Castex et al.
(2020). The Economistâ€™s review uses a sample of U.S. states focusing on the case-fatality rate. It finds the
following associations between the case-fatality rate and the listed variables, ordered by their significance
(one standard deviation increase): median age (pos.), ICU beds per 100,000 people (neg.), population
density (pos.), and median income (neg.), the prevalence of heart disease, diabetes and smoking (pos.),
the share of the population that is African-American (pos.), and amount of social distancing three weeks
prior (neg.). Stojkoski et al.â€™s study finds that greater government intervention, measured by a slight
variant of the stringency index used in our research, is associated lower mortality per capita. Our results
are consistent with this. Given our most comprehensive specification in the cross-country estimates, we
find a significant association between the stringency index and the mortality rate peak levels (Table 2,
20

column [1]). An increase of 1 unit of the stringency index is statistically associated with -12 percent
decrease in the first peak mortality rate (Table 2, column [1]). Our cross-country results revealing
heterogeneity effects of government interventions on COVID-19 mortality growth rates also relate to those
findings of Castex et al. (2020) on the COVID-19 transmission rates; that the effectiveness of nonpharmaceutical interventions (such as school and workplace closures) is increasing with lower air
pollution and higher health expenditure. They also find that the effectiveness of such interventions is
declining with higher proportion of elderly population, which seems to contradict with our results. One
potential reason could be the dependent variables are different, with us focusing on mortality rates and
them focusing on transmission rates.33
V. ii. Demographics and culture
Our study finds supportive evidence for the role of the aging population, urbanization, pre-existing
conditions, mortality from high-blood pressure, obesity, diabetes, and trust. The findings are consistent
with case studies on the association between social networks and COVID-19 infection. Kuchler, Russel,
and Stroebel (2020) find in Facebook data that areas with stronger social ties to two early COVID-19
â€œhotspotsâ€ (Westchester County, NY, in the U.S. and Lodi province in Italy) generally have more
confirmed COVID-19 cases, after controlling for geographic distance to the hotspots as well as for the
income and population density of the regions. Allcott et al. (2020) find in location data from a large sample
of smartphones to show that areas with more Republicans engage in less social distancing (controlling for
other factors including state policies, population density, and local COVID cases and deaths, pointing to
significant gaps between Republicans and Democrats in beliefs about personal risk and the future path of
the pandemic. Fetzer et al. (2020) find that the perception of a weak government and public response is
associated with higher levels of worries and depression, and those strong government reactions correct
misperceptions and reduce worries and depression. Our findings on the association between trust, the
stringency index, and mortality from COVID-19 yield consistent messages along this line.
V.iii. Geography

33

On one hand, countries with a higher proportion of elderly population may see a lower level of social contact,
and therefore, exhibit a smaller effect of limiting social contact on reducing transmission rates. On the other hand,
countries with a higher proportion of elderly population may have a higher mortality rate, and therefore, benefit
more from such interventions.

21

We find that the mortality growth rates are associated with the impact of stringency policies
interacted with distance from the equator: countries in higher latitude appear to benefit more from
stringency policies, as they are associated with lower mortality growth from an equivalent rise in
stringency relative to countries which lie closer to the equator. This evidence suggests that geographic
location may be a potential COVID-related risk factor such that stringency measures are more effective
in higher risk, high latitude countries. The finding is consistent with evidence linking temperatures to the
spread of influenza. Slusky and Zeckhauser (2019) find that sunlight strongly protects against influenza,
a relationship driven by sunlight in late summer, and early fall (when there are sufficient quantities of both
sunlight and influenza activity).
V. iv. Government policies
Across countries, our estimates suggest that government policy, institutions, and the intensity of
government response to COVID-19 are negatively associated with the mortality per capita. This evidence
reflects in the coefficient estimates of stringency index, government effectiveness, democracy, health
expenditures, vulnerable employees, capita GNI, and level pollution. These cross-country findings are
consistent with several case studies of COVID-19. Dave et al. (2020) find in the data of U.S. states that
approximately three weeks following the adoption of a Shelter-in-Place Orders (SIPO), cumulative
COVID-19 cases fell by 44 percent and, in an event-study analysis, that SIPO-induced case reductions
grew larger over time, with the early adopters and high population density states appear to reap larger
benefits from their SIPOs, though the estimated mortality reduction effects were imprecisely estimated.
This finding is consistent with our estimates of the stringency index under the local projection approach.
Our finding in the cross-country data on the importance of the extent of vulnerable employees is
largely consistent with the evidence from influenza. Markowitz, Nesson, and Robinson (2019) find in the
U.S. data that a one percentage point increase in the employment rate increases the number of influenzarelated doctor visits by about 16 percent; these effects are highly pronounced in the retail sector and
healthcare sector, the sectors with the highest levels of interpersonal contact. Clay, Lewis, and Sevenini
(2018) find evidence on the link between air pollution and influenza infection and suggest that poor air
quality was an important cause of mortality during the pandemic.
The empirical issues remain on the endogeneity of mobility and in-bound/out-bound travels to
government response in the estimation. For instance, Gupta et al. (2020) find that mobility fell
substantially in all the U.S. states, even ones that have not adopted major distancing mandates. They find
that there is little evidence, for example, that stay-at-home mandates induced distancing; in contrast, early
22

and information-focused actions have had bigger effects. Their event studies show that first case
announcements, emergency declarations, and school closures reduced mobility by 1-5% after 5 days and
7-45% after 20 days. We are in the process of addressing endogenous regressors in our estimation (policy
stringency, lagged mortality, and mobility) with more updated data.
VI. Future research and closing remarks
We conclude by cautioning that our results are subject to data limitations, including undercounts
of COVID-19 infections and mortality. â€˜Better or worse performanceâ€™ of a country in the first phase of
the pandemic does not guarantee similar future outcomes. The levels of COVID-19 policy stringency
applied in the first wave were correlated with several pre-conditions [aging population, urbanization,
travels, income, health spending, and democracy], the correlations that might influence the policy
efficiency in the following wave(s) if any. Flattening the mortality and infection curves may shift mortality
and painful adjustment forwards. Premature opening of the economy without proper testing, contacttracing, and selective quarantines of vulnerable or impacted segments of the population may induce future
acceleration of the pandemic (Acemoglu et al., 2020). More medical research and advances towards better
treatment and possible vaccinations, the quality of local and global public policies, and adjustment
capabilities of countries will determine future dynamics of the pandemic (Lipsitch et al., 2020).

References
Acemoglu D, Chernozhukov V., Werning I., Whinston MD (2020) A Multi-Risk SIR Model with Optimally
Targeted Lockdownm, NBER Working Paper No. 27102.
Allcott H, Boxell L, Conway JC, Gentzkow M, Thaler M, Yang DY (2020) Polarization and Public Health:
Partisan Differences in Social Distancing during the Coronavirus Pandemic, NBER Working Paper No.
26946.
Atkeson A (2020) How Deadly Is COVID-19? Understanding The Difficulties With Estimation Of Its Fatality
Rate, NBER Working Paper No. 26965.
Avery C, Bossert W, Clark A, Ellison G, Ellison SF (2020) Policy Implications of Models of the Spread of
Coronavirus: Perspectives and Opportunities for Economists, NBER Working Paper No. 27007.
Bloomberg (2020) Did Japan Just Beat the Virus Without Lockdowns or Mass Testing? 2020-05-23.
Castex G., Dechter E., Lorca M. (2020) COVID-19: Cross-country heterogeneity in effectiveness of nonpharmaceutical interventions. Covid Economics, 175.
Centers for Disease Control and Prevention (2020) COVID-19 Pandemic Planning Scenarios,
https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html#table-2 (accessed July 2nd,
2020).
Clay K. Lewis J, Severnini E (2018) Pollution, Infectious Disease, and Mortality: Evidence from the 1918
Spanish Influenza Pandemic, Journal of Economic History, 1179-1209.

23

Cox DR (1972) Regression models and lifeâ€tables. Journal of the Royal Statistical Society: Series B
(Methodological) 34, no. 2, 187-202.
Dave DM, Friedson AI, Matsuzawa K, Sabia JJ (2020) When Do Shelter-in-Place Orders Fight COVID-19 Best?
Policy Heterogeneity Across States and Adoption Time, NBER Working Paper No. 27091.
Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted
residuals, Biometrika, Volume 81, Issue 3, Pages 515â€“526, https://doi.org/10.1093/biomet/81.3.515
George B, Seals S, Aban I (2014), Survival analysis and regression models, Journal of Nuclear Cardiology, 21, 4,
686-694.
Gupta S et al (2020) Tracking Public and Private Responses to the COVID-19 Epidemic: Evidence from State and
Local Government Actions, NBER Working Paper No. 27027.
Fetzer TR et al (2020) Global Behaviors and Perceptions at the Onset of the COVID-19 Pandemic, NBER
Working Paper No. 27082.
Kuchler T, Russel, D Stroebel J (2020) The Geographic Spread of COVID-19 Correlates with Structure of Social
Networks as Measured by Facebook, NBER Working Paper No. 26990.
Lipsitch M, Swerdlow DL, Finelli L (2020) Defining the epidemiology of COVID-19â€”studies needed." New
England Journal of Medicine 382.13: 1194-1196.
JordÃ  Ã’ (2005) Estimation and inference of impulse responses by local projections. American economic review
95.1, 161-182.
Judson RA, Owen AL (1999) Estimating dynamic panel data models: a guide for macroeconomists. Economics
letters 65.1: 9-15.
Liu L, Hyungsik RM, Schorfheide F (2020), Panel Forecasts of Country-Level Covid-19 Infections, NBER
Working Paper No. 27248.
McAloon CG et al (2020) The incubation period of COVID-19: A rapid systematic review and meta-analysis of
observational research. medRxiv doi: https://doi.org/10.1101/2020.04.24.20073957,
Manski CF, Molinari F (2020) Estimating the COVID-19 Infection Rate: Anatomy of an Inference Problem,
NBER Working Paper No. 27023.
Markowitz, Sara, Nesson, Erik, and Robinson, Joshua J.,2019, The effects of employment on influenza rates,
Economics & Human Biology, 34, 286-295.
Nickell S. (1981) Biases in Dynamic Models with Fixed Effects. Econometrica, vol. 49, no. 6, 1417â€“1426.
JSTOR, www.jstor.org/stable/1911408.
Ramey VA, Zubairy S (2018). Government spending multipliers in good times and in bad:
evidence from US historical data. Journal of Political Economy, 126(2), pp.850-901.
Slusky D, Zeckhauser RJ (2019) Sunlight and Protection Against Influenza, NBER Working Paper No. 24340.
Stojkoski at al (2020) The socio-economic determinants of the coronavirus disease (COVID-19) pandemic,
arXiv:2004.07947 [physics.soc-ph]
The Economist (2020) The South Is Likely to Have America's Highest Death Rate from COVID-19.
www.economist.com/graphic-detail/2020/04/25/the-south-is-likely-to-have-americas-highest-death-ratefrom-COVID-19.
The Economist (2020) COVID-19 May Be Far More Prevalent than Previously Thought.
www.economist.com/graphic-detail/2020/04/01/COVID-19-may-be-far-more-prevalent-than-previouslythought.
Van Bavel JJ et al (2020). Using social and behavioural science to support COVID-19 pandemic response. Nature
Human Behaviour, 4, 1-12. https://doi.org/10.1038/s41562-020-0884-z
Verity R et al (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet
Infectious Diseases, 30-03-2020. https://doi.org/10.1016/S1473-3099(20)30243-7

24

Figure 1.1 and 1.2 COVID-19 mortality rate curves, by country

LHS (1.1): Cumulative logged mortality rate. RHS (1.2): New Mortality Rate. 7-day rolling averages. Series starts from the
5th COVID-assigned death.

25

Figure 1.3 Sample Countries and New Mortality Curves, 1/23/20-4/28/20

Note: 7-Day rolling average new mortality rate by country. Y-axis normalized to have all countries fit the same scale. Period:
January 23 â€“ April 28, 2020. Special case countries we omit from the above plots: China (a discrete large spike in mortality in
mid-April to account for past reporting delays and omissions), Singapore (highly fluctuating case curves associated to
immigrant workers), and Vietnam (a flat line).

26

Figure 2. Daily New COVID-19 Global Mortalities

Note: Cumulated daily deaths across all countries in the sample.

27

Figure 3. Peak-related dependent variables in country case of Czechia.

Figure 4. Daily new mortality curves of selected countries.

28

Figure 5. The mortality rate is negatively associated with the intensity of government response.

Note: Pooled estimates from local projections are represented as gray circles. Error bars reflect 95% confidence intervals based
on HAC-robust standard errors clustered by country.

Figure 6. Mortality impacts: government response, demographics, geography, and development level.

Note: Red squares (blue circles) represent the local projection impact from a 10-unit higher stringency index on mortality
growth for countries in the 75th percentile (25th percentile) of the country characteristic.

29

Figure 7. Time-to-peak duration analysis of mortality rates.

Note: Y-axis indicates the probability the peak mortality/case is â€˜yet to comeâ€™. The higher y-axis implies a lower probability of
peaking. X-axis reflects the number of days since the first mortality/case was realized. Shaded areas represent 95% confidence
intervals.

30

Table 1. Mortality Projection â€“ Average Impact
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Stringency (t)
New Mortality Growth
(t-1)
Fixed effects?
Observations
R2
F Statistic
Note:

-0.021984***
(0.007866)

-0.016790***
(0.004940)

-0.012890***
(0.004888)

0.103532

0.031686

-0.001775

(0.074386)

(0.033875)

(0.041413)

Y
1,266
0.086550
53.818610***

Y
929
0.048007
20.372910***

Y
590
0.026846
6.648424***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

Table 2. Explaining Cross-Country Differences in the Empirical Shape of Mortality Rate Curve from the Onset to the Local Peak of the First Pandemic
Phase.

31

Dependent variable:
Log(Peak New Mortality Rate)

Intercept

Log(Peak New Moratlity Rate)-to- Survival Probability of Mortality
PD Ratio
Peaking at Time (t)

OLS

OLS

Cox prop. hazards

(1)

(2)

(3)

-17.751***

-3.487***

(5.398)

(1.316)

Log(Peak Mortality)

-0.389**
(0.198)

Log(Early Mortality)
Early Mortality Growth

**

-0.133

1.588***

(0.208)

(0.067)

(0.320)

0.428

0.123

0.231
***

(0.143)
Early SI
Days between First SI and First Death
Stringency Delta
Early Mobility
Prop. 65+
Prop. Urban
Pop. Density
Vulnerable Emp.
Log(GNI)
EIU Democracy
Latitude:Longitude

Observations

*

-0.331

(0.070)

(0.258)

-0.120*

-0.009

0.097

(0.073)

(0.012)

(0.081)

0.016

0.001

-0.033*

(0.015)

(0.003)

(0.019)

0.150

0.070

-0.244

(0.160)

(0.054)

(0.239)

0.017**

0.001

-0.012

(0.007)

(0.001)

(0.008)

0.036

0.002

0.124**

(0.045)

(0.009)

(0.050)

0.002

-0.002

-0.008

(0.014)

(0.003)

(0.018)

-0.0001

-0.00004*

0.0003*

(0.0001)

(0.00003)

(0.0002)

-0.014

-0.003

0.109***

(0.017)

(0.003)

(0.033)

0.519

0.089

1.008*

*

(0.299)

(0.064)

(0.585)

-0.011

-0.013

-0.441**

(0.123)

(0.026)

(0.222)

-0.0001

0.00001

-0.0005***

(0.0001)

(0.00001)

(0.0001)

49

49

49

R2

0.763

0.496

0.788

Adjusted R2

0.674

0.309

1.018

0.254

8.647***

2.653**

Log Likelihood
Residual Std. Error
F Statistic

-89.867

Wald Test

46.790***

LR Test

75.978***

PH Test p-value
Note:

0.05
*,**,*** correspond to 10%, 5% and 1% significance, respectively.
PH Test refers to testing the proportional hazards assumption (Grambsch and Therneau (1994)).
Null hypothesis is the assumption is not violated.
Standard errors in linear models are Heteroscedastic-Robust standard errors.

32

Table 3. Correlations of mortality rates, government responses, and country characteristics.
a. Correlation Matrix of Key Variables

33

b. Correlation Matrix of COVID-19 Pandemic Policy Intervention Data

Note: We consider pandemic policy interventions, which refer to containment and closure policies, as well as public information
campaign in the Oxford COVID-19 Government Response Tracker (OxCGRT). The Stringency Index is a weighted average
of the scores of these pandemic policy interventions.

34

c. Country Characteristics: Summary
N Minimum Maximum
PD to Peak Mortality
58
58
Early Mortality 10
Early Mortality Growth
58
58
Peak New Mortality 10
Logged Peak Mortality-to-PD
58
Early SI
55
Days from First SI to First Death 55
Stringency Delta
55
Early Mobility
51
Prop. 65
58
Prop. Urban
58
Pop. Density
58
Vulnerable Employment
58
Health Expenditure
58
Log(GNI)
58
Pollution
58
Latitude
58
Longitude
58
Democracy
58

Mean

Median

S.D.

3
85
33.983
33.500
15.550
0.022
67.944
8.055
2.865
13.840
0
3.611
1.369
1.386
0.990
0.368
287.696
32.445
8.339
55.498
-5.492
-0.187
-0.655
-0.417
0.907
0
27.450
7.773
6.309
5.891
-8
79
32.855
32
22.047
0.479
5.930
1.713
1.301
1.181
26.130
149.684
92.657
96.114
31.365
1.085
27.576
14.004
15.212
6.442
34.030
100
76.513
80.238
15.141
3.249 7,952.998 295.055 107.557 1,047.129
0.144
74.270
16.513
10.662
15.229
69.293 10,246.140 2,615.687 1,589.132 2,453.654
7.611
11.343
9.965
10.147
0.969
5.861
91.187
22.256
16.030
21.446
-40.901
64.963
31.292
38.027
27.425
-106.347 174.886
24.668
19.324
61.076
1.930
9.870
7.088
7.510
1.991

35

25th Percentile 75th Percentile
26
0.863
0.693
2.032
-0.514
3.633
15.500
0.969
65.111
8.479
67.027
32.179
7.396
666.110
9.256
10.392
23.477
2.778
6.605

40
8.204
1.946
29.007
-0.322
10.192
51
1.796
111.594
19.410
87.216
213.004
21.522
4,336.231
10.753
21.295
51
46.881
8.262

Appendix: Accounting for global COVID-19 diffusion patterns, January-April 2020
Yothin Jinjarak,

Rashad Ahmed,

Sameer Nair-Desai,

Weining Xin,

Joshua Aizenman

Table A1.0. Variable Definitions and Sources
Variable
New Mortality Rate

Definition

Source

7-day rolling average of daily new mortality rate out ot the total population

Authors' calculation based on JHU COVID-19 Data

Early Mortality

Cumulative mortality rate in the week following the first death

Authors' calculation based on JHU COVID-19 Data

Early Mortality Growth

Growth rate of new mortality rate in the week following the first death

Authors' calculation based on JHU COVID-19 Data

Peak New Mortality

New mortality rate at the peak of new mortality rate in the first quasi-bell curve

Authors' calculation based on JHU COVID-19 Data

PD to Peak Mortality

Day-to-peak of new mortality rate in the first quasi-bell curve

Authors' calculation based on JHU COVID-19 Data

Logged Peak Mortality-toPD

The ratio of the logged peak new mortality rate to the PD to peak mortality

Authors' calculation based on JHU COVID-19 Data

Early SI

Average of SI from its first non-zero value to the first death

Authors' calculation based on OxCGRT Data

Days from First SI to First
Death

Number of days from first non-zero SI to the first death

Authors' calculation based on OxCGRT Data

Stringency Delta

Growth rate of SI from its first non-zero value to its maximum level

Authors' calculation based on OxCGRT Data

Early Mobility

Weekly average level of mobility in terms of walking in the week prior to the first death, reported by Apple

Authors' calculation based on Apple COVID-19
Mobility Trends Reports

Prop. 65+

Elderly population (people aged 65 and over) as a percentage of the total population

World Development Indicators

Prop. Urban

Urban population as a percentage of the total population

World Development Indicators

Pop. Density

Midyear population divided by land area in square kilometers

World Development Indicators

Vulnerable Employment

Employment in vulnerable sectors (i.e., family workers and own-account workers) as a percentage of the
total employment

World Development Indicators

Health Expenditure

Level of current health expenditure (including healthcare goods and services) as a percentage of GDP

World Development Indicators

Log(GNI)

The logged gross national income per capita

World Development Indicators

Pollution

Population-weighted exposure to ambient PM2.5 pollution

World Development Indicators

Tourist Arrivals

International inbound tourists to the country

World Development Indicators

Tourist Departures

International outbound tourists from the country

World Development Indicators

Latitude

Latitude coordinate of the country

Country-level coordinates from Google

Longitude

Longitude coordinate of the country

Country-level coordinates from Google

Democracy

The Democracy index calculated by The Economist Intelligence Unit

The EIU Democracy Index 2019 Database

Data Sources
Economist Intelligence Unit (2019) Data Publishing Language - Country Coordinates,â€ developers.google.com, Google,
https://developers.google.com/public-data/docs/canonical/countries_csv.
Economist Intelligence Unit (2019) Democracy Index - World Democracy Report, www.eiu.com/topic/democracyindex?&zid=democracyindex2019&utm_source=blog&utm_medium=blog&utm_name=democracyindex2019&utm
_term=democracyindex2019&utm_content=top_link.
Freedom House (2020) Freedom in the World, freedomhouse.org/countries/freedom-world/scores.
International Monetary Fund (2020) Policy Responses to COVID19. www.imf.org/en/Topics/imf-and-COVID19/PolicyResponses-to-COVID-19.
Mobility, apple.com, Apple (2020) https://www.apple.com/COVID19/mobility.
National Material Capabilities (2017) Correlatesofwar.org, Correlates of War, v5.0.
correlatesofwar.org/data-sets/national-material-capabilities.
Novel Coronavirus COVID-19 (2019-nCoV), github.com, JHU CSSE, 2020,
https://github.com/CSSEGISandData/COVID19/blob/master/csse_COVID_19_data/csse_COVID_19_time_series/ti
me_series_COVID19_confirmed_global.csv.
Our World in Data (2020) https://ourworldindata.org/coronavirus-testing.
World Health Organization (2019) International Classification of Diseases (v10.0), icd.who.int/browse10/2019/en.
World Bank (2020) World Development Indicators, data.worldbank.org/indicator.

36

Supplemental Results of Baseline Panel Analysis on New Mortality Growth Rate
Table A1.1. Mortality Projection â€“ Proportion of Age above 65 Population
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(1)
(2)
Stringency (t)
New Mortality Growth (t1)
Stringency (t) X
Proportion 65+
Fixed effects?
Observations
R2
F Statistic
Note:

Weekly New Mortality
Growth (t+28)
(3)

-0.001006
(0.011664)

0.001458
(0.005207)

0.003538
(0.007936)

0.070344

-0.011277

-0.042271

(0.062111)

(0.047846)

(0.050568)

-0.001184**

-0.000978**

-0.000861

(0.000575)

(0.000414)

(0.000576)

Y
1,276
0.072771
29.954000***

Y
933
0.037506
10.534230***

Y
593
0.020423
3.363587**

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

37

Table A1.2. Mortality Projection â€“ Proportion of Urban Population.
Dependent variable:
Weekly New Mortality Growth
(t+14)
(1)

Weekly New Mortality
Growth (t+21)
(2)

Weekly New Mortality
Growth (t+28)
(3)

Stringency (t)

0.005617
(0.016953)

0.004818
(0.008169)

0.009061
(0.011368)

New Mortality Growth (t-1)

0.085230
(0.062211)

0.001939
(0.044643)

-0.029877
(0.046623)

-0.000349*

-0.000262**

-0.000270

(0.000211)

(0.000127)

(0.000188)

Y
1,276
0.070766
29.065970***

Y
933
0.034867
9.766239***

Y
593
0.019492
3.207170**

Stringency (t) X Proportion
Urban
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

38

Table A1.3. Mortality Projection â€“ Latitude.
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Stringency (t)
New Mortality Growth
(t-1)
Stringency (t) X
Latitude
Fixed effects?
Observations
R2
F Statistic
Note:

-0.016482**
(0.008083)

-0.011871***
(0.004488)

-0.004601
(0.005173)

0.083068

0.000937

-0.034184

(0.062968)

(0.045434)

(0.053642)

-0.000078

-0.000052

-0.000132

(0.000090)

(0.000069)

(0.000103)

Y
1,276
0.063921
26.062620***

Y
933
0.030954
8.635236***

Y
593
0.017270
2.835236**

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

39

Table A1.4. Mortality Projection â€“ Longitude.
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Stringency (t)
New Mortality Growth
(t-1)
Stringency (t) X
Longitude
Fixed effects?
Observations
R2
F Statistic
Note:

-0.020795***
(0.006198)

-0.014686***
(0.003615)

-0.010800***
(0.003809)

0.083229

0.001601

-0.024742

(0.064252)

(0.042077)

(0.050609)

0.000075*

0.000059

0.000092**

(0.000040)

(0.000052)

(0.000046)

Y
1,276
0.067552
27.650070***

Y
933
0.033238
9.294305***

Y
593
0.020290
3.341238**

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

40

Table A1.5. Mortality Projection â€“ Population Density.
Dependent variable:

Stringency (t)
New Mortality Growth (t-1)
Stringency (t) X Population
Density
Fixed effects?
Observations
R2
F Statistic
Note:

Weekly New Mortality
Growth (t+14)
(1)

Weekly New Mortality
Growth (t+21)
(2)

Weekly New Mortality
Growth (t+28)
(3)

-0.019453***
(0.006640)

-0.017125***
(0.004184)

-0.008746
(0.006033)

0.088915
(0.060622)

0.008777
(0.041849)

-0.027667
(0.048828)

0.000000

0.000021**

-0.000008

(0.000001)

(0.000010)

(0.000023)

Y
1,276
0.062949
25.639490***

Y
933
0.035617
9.984036***

Y
593
0.015586
2.554293*

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

41

Table A1.6. Mortality Projection â€“ Travel Arrivals.
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Stringency (t)
New Mortality Growth (t1)
Stringency (t) X
Log(Arrivals)
Fixed effects?
Observations
R2
F Statistic
Note:

0.111648**
(0.054341)

0.101309**
(0.042350)

0.126787***
(0.044481)

0.058664

-0.019535

-0.051550

(0.061179)

(0.044369)

(0.049817)

-0.007603**

-0.006653***

-0.007863***

(0.003025)

(0.002429)

(0.002605)

Y
1,276
0.074203
30.590740***

Y
933
0.038917
10.946500***

Y
593
0.025531
4.226886***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

42

Table A1.7. Mortality Projection â€“ Travel Departures.
Dependent variable:
Weekly New Mortality Growth
(t+14)
(1)

Weekly New Mortality
Growth (t+21)
(2)

Weekly New Mortality
Growth (t+28)
(3)

Stringency (t)

-0.007286
(0.068928)

0.026951
(0.054669)

0.081786*
(0.046774)

New Mortality Growth (t-1)

0.094169
(0.060496)

-0.003565
(0.043595)

-0.040745
(0.044961)

-0.000935

-0.002519

-0.005335**

(0.004070)

(0.003104)

(0.002669)

Y
1,145
0.082130
30.482630***

Y
850
0.039163
9.986145***

Y
546
0.018646
2.799441**

Stringency (t) X
Log(Departures)
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

43

Table A1.8. Mortality Projection â€“ Vulnerable Employees.
Dependent variable:

Stringency (t)
New Mortality Growth (t-1)
Stringency (t) X Vulnerable
Employees
Fixed effects?
Observations
R2
F Statistic
Note:

Weekly New Mortality
Growth (t+14)
(1)

Weekly New Mortality
Growth (t+21)
(2)

Weekly New Mortality
Growth (t+28)
(3)

-0.020826***
(0.005034)

-0.018219***
(0.006186)

-0.018106**
(0.007128)

0.088387
(0.062288)

0.002826
(0.044618)

-0.031370
(0.046253)

0.000088

0.000276

0.000523*

(0.000208)

(0.000292)

(0.000316)

Y
1,276
0.063244
25.767680***

Y
933
0.033579
9.392848***

Y
593
0.025218
4.173833***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

44

Table A1.9. Mortality Projection â€“ Income Level.
Dependent variable:
Weekly New Mortality
Growth (t+14)
(1)

Weekly New Mortality
Growth (t+21)
(2)

Weekly New Mortality
Growth (t+28)
(3)

Stringency (t)

0.035894
(0.031427)

0.028850
(0.018368)

0.027754
(0.024123)

New Mortality Growth (t-1)

0.085178
(0.061755)

0.002606
(0.046563)

-0.028715
(0.047679)

-0.005514*

-0.004273**

-0.003785

(0.003015)

(0.001985)

(0.002624)

Y
1,276
0.071900
29.567720***

Y
933
0.036131
10.133590***

Y
593
0.019462
3.202166**

Stringency (t) X Log(GNI per
capita)
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

45

Table A1.10. Mortality Projection â€“ Health Expenditures.
Dependent variable:
Weekly New Mortality
Growth (t+14)
(1)

Weekly New Mortality
Growth (t+21)
(2)

Weekly New Mortality
Growth (t+28)
(3)

Stringency (t)

-0.012473
(0.008092)

-0.005034**
(0.002565)

-0.004308
(0.003159)

New Mortality Growth (t-1)

0.090457
(0.062357)

0.009770
(0.044787)

-0.021132
(0.045583)

-0.000002

-0.000003***

-0.000002

(0.000001)

(0.000001)

(0.000001)

Y
1,276
0.070173
28.804070***

Y
933
0.042075
11.873970***

Y
593
0.019817
3.261793**

Stringency (t) X Health
Expenditures
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

46

Table A1.11. Mortality Projection â€“ Pollution.
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Stringency (t)
New Mortality Growth
(t-1)
Stringency (t) X
Pollution
Fixed effects?
Observations
R2
F Statistic
Note:

-0.026185***
(0.006261)

-0.018337***
(0.004334)

-0.013563**
(0.005423)

0.086254

0.004577

-0.026531

(0.061609)

(0.044548)

(0.048239)

0.000251***

0.000160**

0.000122

(0.000090)

(0.000067)

(0.000084)

Y
1,276
0.075104
30.992370***

Y
933
0.035749
10.022320***

Y
593
0.018264
3.001416**

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

47

Table A1.12. Mortality Projection â€“ Level of Democracy.
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(1)
(2)
Stringency (t)
New Mortality Growth (t1)
Stringency (t) X EIU
Democracy
Fixed effects?
Observations
R2
F Statistic
Note:

Weekly New Mortality
Growth (t+28)
(3)

-0.005800
(0.018837)

0.007013
(0.008324)

0.002435
(0.009397)

0.090181

0.006915

-0.025264

(0.062633)

(0.045217)

(0.047252)

-0.001934

-0.002936**

-0.001761

(0.002256)

(0.001468)

(0.001598)

Y
1,276
0.066536
27.204670***

Y
933
0.038840
10.924170***

Y
593
0.018083
2.971115**

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

48

Robustness Results of Panel Analysis on New Mortality Growth Rate
Table A2.1. Mortality Projection â€“ Average Impact (Logged SI)
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Logged Stringency (t)
New Mortality Growth
(t-1)
Fixed effects?
Observations
R2
F Statistic

-0.710909**
(0.335622)

-0.577075***
(0.187711)

-0.470731***
(0.161767)

0.087405

0.008859

-0.013496

(0.067062)

(0.041834)

(0.042783)

Y
1,276
0.044177
26.483640***

Y
933
0.028483
11.903000***

Y
593
0.018888
4.668460***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.
Note: Specification is same as the benchmark, except that the level measure of SI is replaced by the logarithm transformation
of SI. Results are similar to those in the benchmark.
Note:

Table A2.2. Mortality Projection â€“ Average Impact (Alternative SI [1])
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Stringency (t)
New Mortality Growth
(t-1)
Fixed effects?
Observations
R2
F Statistic

-0.018912***
(0.006718)

-0.014804***
(0.004319)

-0.012165***
(0.004504)

0.093227

0.029326

-0.006721

(0.074240)

(0.037322)

(0.040538)

Y
1,297
0.079926
50.601290***

Y
938
0.044409
18.960860***

Y
592
0.028367
7.050716***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.
Note: Specification is same as the benchmark, except that the SI is replaced by an alternative excluding the public information
campaigns. Results are similar to those in the benchmark.
Note:

49

Table A2.3. Mortality Projection â€“ Average Impact (Alternative SI [2])
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Stringency (t)
New Mortality Growth
(t-1)
Fixed effects?
Observations
R2
F Statistic

-0.017395***
(0.006038)

-0.013944***
(0.004169)

-0.010151***
(0.003723)

0.092050

0.029785

-0.010423

(0.071946)

(0.037462)

(0.040227)

Y
1,297
0.085334
54.344330***

Y
938
0.048988
21.016790***

Y
592
0.024230
5.996885***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.
Note: Specification is same as the benchmark, except that the SI is replaced by an alternative excluding the public information
campaigns and international travel restrictions. Results are similar to those in the benchmark.
Note:

Table A2.4. Mortality Projection â€“ Average Impact (Lagged SI)
Dependent variable:
Weekly New Mortality Growth Weekly New Mortality Growth Weekly New Mortality Growth
(t+14)
(t+21)
(t+28)
(1)
(2)
(3)
Stringency (t)

-0.013319**
(0.005999)

-0.010201***
(0.003345)

-0.007504*
(0.004347)

Stringency (t-1)

-0.006240**
(0.002865)

-0.003815
(0.002528)

-0.002709
(0.003899)

0.087064

0.004278

-0.024800

(0.060272)

(0.043168)

(0.046638)

Y
1,276
0.065489
26.746620***

Y
933
0.031600
8.821250***

Y
593
0.015925
2.610737*

New Mortality Growth
(t-1)
Fixed effects?
Observations
R2
F Statistic

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.
Note: Specification is same as the benchmark, except that a one-day lagged SI is added. Results are similar to those in the
benchmark.
Note:

50

Robustness Results of Panel Analysis on Cumulative Mortality Growth Rate

Figure A1.1. The cumulative mortality growth rate is negatively associated with the intensity of government response.

Note: Results of panel analysis on cumulative mortality growth rates. Pooled estimates from local projections are represented
as gray circles. Error bars reflect 95% confidence intervals based on HAC-robust standard errors clustered by country.

51

Figure A1.2. Cumulative mortality growth impacts: government response, demographics, geography, and development level.

Note: Results of panel analysis on cumulative mortality growth rates. Red squares (blue circles) represent the local projection
impact from a 10-unit higher stringency index on mortality growth for countries in the 75th percentile (25th percentile) of the
country characteristic.

52

Table A2.0. Mortality Projection â€“ Average Impact.
Dependent variable:
Cum. Mortality Growth (t+14) Cum. Mortality Growth (t+21) Cum. Mortality Growth (t+28)
(1)
(2)
(3)
Stringency (t)
Cum. Mortality Growth (t-1)
Fixed effects?
Observations
R2
F Statistic
Note:

-0.009200***
(0.002854)

-0.009962***
(0.002310)

-0.010049***
(0.002342)

0.055148
(0.046278)

0.017638
(0.031291)

-0.027729
(0.024830)

Y
1,399
0.122776
88.734250***

Y
1,040
0.214357
125.235100***

Y
689
0.300179
124.391700***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

53

Table A2.1. Mortality Projection â€“ Proportion of Age above 65 Population
Dependent variable:
Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

Stringency (t)

0.001965
(0.002812)

-0.004367
(0.003560)

-0.006794*
(0.003727)

Cum. Mortality Growth (t-1)

0.022421
(0.046730)

0.000552
(0.029896)

-0.039041
(0.030053)

-0.000781***

-0.000387*

-0.000224

(0.000153)

(0.000227)

(0.000208)

Y
1,399
0.189555
98.779660***

Y
1,040
0.239247
96.128210***

Y
689
0.310549
86.933060***

Stringency (t) X Proportion
65+
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

54

Table A2.2. Mortality Projection â€“ Proportion of Urban Population.
Dependent variable:
Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

Stringency (t)

0.004059
(0.006513)

-0.003662
(0.006154)

-0.004190
(0.005651)

Cum. Mortality Growth (t-1)

0.038079
(0.048777)

0.008961
(0.030359)

-0.036625
(0.027817)

-0.000192**

-0.000092

-0.000086

(0.000095)

(0.000088)

(0.000080)

Y
1,399
0.153645
76.669000***

Y
1,040
0.224490
88.482590***

Y
689
0.310667
86.980680***

Stringency (t) X Proportion
Urban
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

55

Table A2.3. Mortality Projection â€“ Latitude.
Dependent variable:
Cum. Mortality Growth (t+14) Cum. Mortality Growth (t+21) Cum. Mortality Growth (t+28)
(1)
(2)
(3)
Stringency (t)

-0.003163
(0.003043)

-0.007922***
(0.002473)

-0.010059***
(0.002792)

Cum. Mortality Growth (t-1)

0.030825
(0.047107)

0.010153
(0.031320)

-0.027692
(0.028863)

Stringency (t) X Latitude

-0.000175***
(0.000052)

-0.000057*
(0.000030)

0.0000003
(0.000056)

Fixed effects?
Observations
R2
F Statistic

Y
1,399
0.168633
85.665170***

Y
1,040
0.221070
86.751910***

Y
689
0.300179
82.784910***

Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

56

Table A2.4. Mortality Projection â€“ Longitude.
Dependent variable:
Cum. Mortality Growth (t+14) Cum. Mortality Growth (t+21) Cum. Mortality Growth (t+28)
(1)
(2)
(3)
Stringency (t)

-0.012039***
(0.003002)

-0.010779***
(0.002483)

-0.010322***
(0.002485)

Cum. Mortality Growth (t-1)

0.021155
(0.050295)

0.005929
(0.030332)

-0.032775
(0.028980)

Stringency (t) X Longitude

0.000089***
(0.000015)

0.000030*
(0.000018)

0.000012
(0.000022)

Y
1,399
0.207271
110.425100***

Y
1,040
0.228580
90.572260***

Y
689
0.302867
83.848020***

Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

57

Table A2.5. Mortality Projection â€“ Population Density.
Dependent variable:

Stringency (t)
Cum. Mortality Growth (t-1)
Stringency (t) X Population
Density
Fixed effects?
Observations
R2
F Statistic
Note:

Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

-0.009641***
(0.002961)

-0.011080***
(0.002783)

-0.011782***
(0.003231)

0.054927
(0.046076)

0.016861
(0.029851)

-0.029213
(0.023432)

0.000001*

0.000006

0.000010

(0.000001)

(0.000004)

(0.000010)

Y
1,399
0.126515
61.170710***

Y
1,040
0.220220
86.324130***

Y
689
0.306982
85.492120***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

58

Table A2.6. Mortality Projection â€“ Travel Arrivals.
Dependent variable:
Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

Stringency (t)

0.105422***
(0.021222)

0.057881**
(0.025567)

0.038960*
(0.019903)

Cum. Mortality Growth (t-1)

0.014701
(0.042305)

-0.005585
(0.025237)

-0.046564*
(0.025268)

-0.006690***

-0.003951***

-0.002845**

(0.001261)

(0.001513)

(0.001119)

Y
1,399
0.241832
134.711500***

Y
1,040
0.276938
117.072500***

Y
689
0.339263
99.097950***

Stringency (t) X
Log(Arrivals)
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

59

Table A2.7. Mortality Projection â€“ Travel Departures.
Dependent variable:
Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

Stringency (t)

0.020893
(0.046732)

0.016164
(0.033627)

0.004469
(0.026610)

Cum. Mortality Growth (t-1)

0.043333
(0.041034)

-0.021901
(0.026964)

-0.041557
(0.028191)

-0.001991

-0.001703

-0.000896

(0.002733)

(0.001955)

(0.001594)

Y
1,230
0.288212
149.278200***

Y
922
0.446255
216.246000***

Y
606
0.450532
136.656900***

Stringency (t) X
Log(Departures)
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

60

Table A2.8. Mortality Projection â€“ Vulnerable Employees.
Dependent variable:

Stringency (t)
Cum. Mortality Growth (t-1)
Stringency (t) X Vulnerable
Employees
Fixed effects?
Observations
R2
F Statistic
Note:

Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

-0.011462***
(0.003532)

-0.009805***
(0.003203)

-0.011427***
(0.003021)

0.045639
(0.049659)

0.018350
(0.029842)

-0.034410
(0.027895)

0.000126

-0.000009

0.000080

(0.000125)

(0.000102)

(0.000090)

Y
1,399
0.131440
63.912280***

Y
1,040
0.214422
83.430920***

Y
689
0.306190
85.174300***

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

61

Table A2.9. Mortality Projection â€“ Income Level.
Dependent variable:
Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

Stringency (t)

0.023814**
(0.011607)

0.006932
(0.011471)

0.003056
(0.010972)

Cum. Mortality Growth (t-1)

0.035574
(0.047994)

0.007080
(0.030226)

-0.037246
(0.028383)

-0.003363***

-0.001723

-0.001339

(0.001248)

(0.001194)

(0.001133)

Y
1,399
0.166610
84.431930***

Y
1,040
0.231623
92.141630***

Y
689
0.312807
87.852690***

Stringency (t) X Log(GNI per
capita)
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

62

Table A2.10. Mortality Projection â€“ Health Expenditures.
Dependent variable:
Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

Stringency (t)

-0.004753*
(0.002802)

-0.007166***
(0.002495)

-0.008221***
(0.002472)

Cum. Mortality Growth (t-1)

0.040067
(0.050194)

0.008104
(0.030674)

-0.034544
(0.026221)

-0.000002**

-0.000001

-0.000001

(0.000001)

(0.000001)

(0.0000004)

Y
1,399
0.166622
84.439430***

Y
1,040
0.239285
96.148390***

Y
689
0.312900
87.890620***

Stringency (t) X Health
Expenditures
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

63

Table A2.11. Mortality Projection â€“ Pollution.
Dependent variable:
Cum. Mortality Growth (t+14) Cum. Mortality Growth (t+21) Cum. Mortality Growth (t+28)
(1)
(2)
(3)
Stringency (t)

-0.012509***
(0.002950)

-0.012391***
(0.002463)

-0.012884***
(0.002850)

Cum. Mortality Growth (t-1)

0.055933
(0.047249)

0.019301
(0.032324)

-0.025354
(0.026997)

Stringency (t) X Pollution

0.000131***
(0.000050)

0.000094**
(0.000046)

0.000105***
(0.000032)

Fixed effects?
Observations
R2
F Statistic

Y
1,399
0.147707
73.192440***

Y
1,040
0.234290
93.527020***

Y
689
0.331865
95.863660***

Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

64

Table A2.12. Mortality Projection â€“ Level of Democracy.
Dependent variable:
Cum. Mortality Growth
(t+14)
(1)

Cum. Mortality Growth
(t+21)
(2)

Cum. Mortality Growth
(t+28)
(3)

Stringency (t)

-0.000268
(0.008155)

-0.002780
(0.005876)

-0.002562
(0.004129)

Cum. Mortality Growth (t-1)

0.053390
(0.048881)

0.015681
(0.032354)

-0.030187
(0.026039)

-0.001277

-0.001015

-0.001059

(0.001078)

(0.000792)

(0.000665)

Y
1,399
0.135608
66.256860***

Y
1,040
0.226321
89.415500***

Y
689
0.315627
89.009980***

Stringency (t) X EIU
Democracy
Fixed effects?
Observations
R2
F Statistic
Note:

*,**,*** correspond to 10%, 5% and 1% significance, respectively.
HAC robust standard errors, clustered by country. Time and Country FEs.

65

Results of Residual Analysis
Figure A2.1. Global Distribution of Residuals of Cross-Country Analysis - Peak Mortality Rate.

Note: Residuals are calculated from cross-country regression specified in Column [1] of Table 2, with the omission of the
â€œEarly Mobilityâ€ for a greater country coverage.

Table A3.1. List of Countries that are the Most Over-Predicted and Under-Predicted.
(a) Top Five Over-Predicted Countries
Country
Australia
Japan
Thailand
Korea, South
China

(b) Top Five Under-Predicted Countries

Residual

Country

Residual

-2.343
-1.670
-1.580
-1.542
-1.479

France
Peru
Belgium
Kuwait
Ireland

2.715
2.207
2.140
1.862
1.589

Note: Residuals are calculated from cross-country regression specified in Column [1] of Table 2, with the omission of the
â€œEarly Mobilityâ€ for a greater country coverage.

66

Figure A2.2. Global Distribution of Residuals of Cross-Country Analysis - Peak Mortality Rate-to-PD Ratio.

Note: Residuals are calculated from cross-country regression specified in Column [1] of Table 2, with the omission of the
â€œEarly Mobilityâ€ for a greater country coverage.

Table A3.2. List of Countries that are the Most Over-Predicted and Under-Predicted.
(a) Top Five Over-Predicted Countries

(b) Top Five Under-Predicted Countries

Country

Residual

Country

Residual

Jordan
Iceland
India
China
Austria

-3.256
-1.176
-0.937
-0.474
-0.473

Egypt
Hungary
Kuwait
Peru
Belgium

0.682
0.667
0.633
0.601
0.546

Note: Residuals are calculated from cross-country regression specified in Column [1] of Table 2, with the omission of the
â€œEarly Mobilityâ€ for a greater country coverage.

67

